UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): November 5, 2007
CNS RESPONSE, INC.
(Exact name of registrant as specified in its charter)
| | Delaware | 0-26285 | 87-0419387 | |
| | (State or other jurisdiction | (Commission File Number) | (I.R.S. Employer | |
| | of incorporation) | | Identification No.) | |
2755 Bristol Street, Suite 285
Costa Mesa, California 92626
(Address of Principal Executive Offices/Zip Code)
(714) 545-3288
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange ct (17 CFR 240.14d-2(B))
o Pre-commencement communications pursuant to Rule 13e-4(c)) under the Exchange Act (17 CFR 240.13e-4c))
Item 7.01 | Regulation FD Disclosure |
A copy of material which was used in an investor presentation delivered by CNS Response, Inc. representatives on Monday November 5, 2007 is attached to this Current Report on Form 8-K as Exhibit 99.1.
The statements made by representatives of CNS Response, Inc. were forward looking statements regarding the Company’s milestones for 2008 and its performance. Various factors could affect future results and could cause actual results to differ materially from those expressed in or implied by these forward-looking statements. Some of those factors are identified in the Company’s periodic reports filed with the Securities and Exchange Commission.
| Item 9.01. | Financial Statements and Exhibits |
(d) | Exhibits. | |
| | The following exhibit is filed herewith: |
| | Exhibit Number | Description |
| | | |
| | 99.1 | Investor Presentation Material |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
| | CNS Response, Inc. |
|
|
|
| Date: November 5, 2007 | By: | /s/ Horace Hertz |
| |
Horace Hertz |
| | Chief Financial Officer |
EXHIBIT INDEX
Exhibit Number | | Description of Exhibit |
| | | |
99.1 | | Investor Presentation Material |
